<ѻý>Genotype Tied to Azathioprine Discontinuation for Toxicityѻý> Nearly threefold risk seen with a genotype most common among Black patients Jun 20, 2022
<ѻý>TYK2 Inhibitor Shows Promise in Lupusѻý> Latest indication for deucravacitinib seen as approvable for multiple rheumatologic conditions Jun 04, 2022
<ѻý>Trial Upends Guidelines on Long-Term Steroids in Rheumatoid Arthritisѻý> Vindication for clinicians who ignored official recommendations Jun 03, 2022
<ѻý>European Docs See Smooth Post-COVID Future in Rheumatologyѻý> Many long-term impacts inevitable, but EULAR attendees mostly optimistic Jun 02, 2022
<ѻý>Can Methotrexate Treat Arthritis Before It Becomes Arthritis?ѻý> Mainstay drug for RA helpful in disease's earliest stage Jun 02, 2022
<ѻý>Air Pollution and Illness: It's Not Just the Lungs and Heart Anymoreѻý> Expanding range of conditions caused or aggravated by fine particulates Jun 01, 2022
<ѻý>Day in the Life of a Doctor: Three Hospitals in One Dayѻý> Go on call with rheumatologist and YouTuber Siobhan Deshauer, MD May 12, 2022
<ѻý>Could an Available Drug Stop Dupuytren's in Its Tracks?ѻý> Phase II trial shows promise in early-stage disease May 03, 2022
<ѻý>One Benefit We Don't See From RA Biologicsѻý> One might have hoped that these agents would help patients stay on the job May 02, 2022
<ѻý>In Lupus, 'Normal-Appearing' Skin Is Not Normalѻý> Groundwork for inflammation laid before lesions develop Apr 27, 2022
<ѻý>Testing for Th/To Antibodies May Help in Scleroderma Managementѻý> Test identifies patients at high risk for pulmonary hypertension Apr 25, 2022
<ѻý>Biologics for JIA? Not So Fast, Say Insurersѻý> Nearly all required prior authorization in a small study, and requests often rejected at first Apr 24, 2022
<ѻý>Day in the Life of a Doctor: Pediatric Rheumatologyѻý> YouTuber Siobhan Deshauer, MD, brings us along for her pediatric rheumatology rotation Apr 07, 2022
<ѻý>Toward More Uniform Methotrexate Dosing in Psoriasisѻý> International expert group urges common standards Mar 30, 2022
<ѻý>'It's an Alien Knee in There': Mixed Feelings After Joint Replacementѻý> Study highlights common, but rarely discussed, problem Mar 28, 2022
<ѻý>Glaucoma: The Newest Autoimmune Disease?ѻý> Researchers argue for a "paradigm shift" Mar 21, 2022
<ѻý>Reassurance on Steroid Shots for Knee OAѻý> Study counters fears that injections worsen underlying pathology Mar 17, 2022
<ѻý>Mixed Results for Oral Lupus Drug in Phase IIѻý> Mid-stage study offers hope but also reason for caution Mar 16, 2022
<ѻý>Ankylosing Spondylitis: Another Step Toward Individualized Therapyѻý> Study IDs factors predicting response to TNF inhibitors Mar 15, 2022
<ѻý>Hopes Dashed for Novel Osteoarthritis Treatmentѻý> Noninvasive therapy looked like a sure winner until trial results came in Mar 08, 2022
<ѻý>Fibromyalgia Patients See Rapid Benefit From Low-Cal Dietѻý> With marked symptom reduction in just 3 weeks, weight loss not a factor Mar 02, 2022
<ѻý>Kids With IBD Need Close Monitoring as They Grow Upѻý> Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
<ѻý>10 ѻý With the Lowest Hourly Rateѻý> Calculated by annual salary divided by number of hours worked Feb 23, 2022
<ѻý>Dyspnea in Woman With RA Reveals a Diaphragmatic Lipomaѻý> MRI can help differentiate these benign soft-tissue masses from more aggressive liposarcomas Feb 22, 2022
<ѻý>Predicting Treatment Response in Inflammatory Muscle Disordersѻý> Swedish registry study elicits factors associated with improvement Feb 16, 2022
<ѻý>Two Years On, Tremfya Still Shines in Psoriatic Arthritisѻý> Efficacy increases in long-term extension data Feb 10, 2022
<ѻý>Mystery: Why Would Hand OA Be Less Severe in Black People?ѻý> Data contrast with previous findings for hip and knee osteoarthritis Feb 04, 2022
<ѻý>Trial Data Confirm Heightened Risks With JAK Inhibitorѻý> May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
<ѻý>Psoriasis Patients, Docs Want to Do More to Prevent Heart Problemsѻý> Despite well-known cardiovascular risks, most patients currently undertreated Jan 19, 2022
<ѻý>Don't Expect Much From COVID Vax in This Patient Groupѻý> With rituximab on board, even third doses didn't induce meaningful antibody response Jan 13, 2022
<ѻý>Muddled Picture for Antidepressant as Osteoarthritis Pain Relieverѻý> Trial in primary care setting fails to confirm benefit seen in specialty clinics Jan 06, 2022
<ѻý>Biologic Disappoints for Arthritis Achilles' Inflammationѻý> But phase III trial did find some patient-oriented benefits Nov 11, 2021
<ѻý>For Systemic JIA, Start Biologics Earlyѻý> Observational study shows excellent efficacy in systemic pediatric arthritis Nov 10, 2021
<ѻý>HAE Still Drawing Attention From Drugmakersѻý> Two new products show midstage promise in hereditary angioedema Nov 10, 2021
<ѻý>Secukinumab: An Up-and-Coming Option in Giant Cell Arteritis?ѻý> Phase II trial found sustained remission with steroid-sparing effects Nov 10, 2021